BiotechTube
Jubilant Radiopharmacies

Jubilant Radiopharmacies

Portland, United States· Est.
jubilantradiopharmacies.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Jubilant Radiopharmacies, founded in 1995, is a major commercial-scale provider of radiopharmaceutical compounding and distribution services in the United States. It operates a vast network of 42 SPECT pharmacies and 3 PET manufacturing facilities, supported by over 600 professionals and a dedicated in-house courier fleet. The company's business model is built on precision logistics—including 15-minute delivery timeslots and Saturday service—to ensure critical, short-lived diagnostic and therapeutic agents reach hospitals and clinics on schedule. Backed by a $60 million investment for expansion, it is positioned to capitalize on the growing demand in nuclear medicine and theranostics.

OncologyCardiologyNeurology

Technology Platform

Integrated logistics and distribution platform for radiopharmaceuticals, featuring precision scheduling (15-minute timeslots), real-time delivery tracking (GeoTab), online ordering systems, and a network of 42 SPECT pharmacies and 3 PET manufacturing facilities.

Opportunities

The rapid growth of theranostics and targeted radiotherapeutics in oncology creates a surge in demand for reliable compounding and delivery of both diagnostic and therapeutic radiopharmaceuticals.
Expansion of PET imaging applications and an aging population further drive demand for diagnostic nuclear medicine services, which form the company's core business.

Risk Factors

Operational risks include disruptions in the complex, time-sensitive supply chain for radioactive materials.
The company faces intense competition from larger and regional radiopharmacy networks, which could pressure pricing and margins.
The business is also subject to stringent and evolving regulatory oversight from the NRC and FDA.

Competitive Landscape

Jubilant Radiopharmacies is the second-largest radiopharmacy network in the U.S., competing directly with the market leader, Cardinal Health, and other regional players. The landscape is characterized by competition on reliability, geographic coverage, product portfolio breadth, and service features like delivery precision and customer support for large healthcare networks (GPOs/IDNs).

More companies in Radiopharmaceuticals →More companies in United States →